ARCHIVES

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

CTRF Seeks Applications In Clinical Cancer Research.

January 28, 2000